March 13, 2010
Fairmont Copley Plaza Hotel, Boston, Massachusetts
Course Director: Marc B. Garnick, MD
Co-Director: Lowell E. Schnipper, MD
Two aspects of four common cancers—breast, colorectal, prostate, and thoracic—encountered in primary care practices that result in a
disproportionate number of medical malpractice claims will be addressed.
- Current approaches to cancer screening, diagnosis, test selection, follow‑up, and key issues for the primary care physician/internist regarding the possible presence of cancer will be discussed. Presentations are directed to both the physician and non‑physician audience and will focus on acceptable practice standards for considering a cancer diagnosis in the primary care setting.
- Medical malpractice issues faced by primary care physicians will be reviewed when a failure to diagnose common cancers occurs.
- Critical factors in processes and procedures will be analyzed that may be of assistance to help minimize risks and exposures. Loss of chance resulting from a failure to diagnose or delayed diagnoses will be fully discussed. A detailed multidisciplinary discussion will highlight considerations for minimizing malpractice claims.
- The lead faculty is selected predominantly from Harvard Medical School (HMS) and Harvard’s Risk Management Foundation (RMF) including clinicians, experts in risk management, insurance professionals, and malpractice attorneys.
WHO SHOULD ATTEND?
Primary care physicians, nurse practitioners, physician assistants, medical malpractice attorneys, insurance medical malpractice and claims
professionals, risk management professionals, insurance payers for screening and diagnostic procedures, social workers involved in hospital risk
management, internal medicine and family practice residents finishing their training, especially those about to enter private practice, medical students,
and law students.
YOU WILL TAKE HOME
You will take home:
- A comprehensive syllabus of the course presentations.
- An understanding and value of the appropriate use of complete medical histories, screening, and diagnostic tests and their limitations used in primary care medicine for common cancers.
- An understanding of the types of clinical outcomes that can occur when a diagnosis of cancer is delayed or missed.
- Recommendations of processes that primary care practices can implement to minimize malpractice claims.
- Recommendations for improving communication between diagnostic specialists and physicians responsible for ordering tests.
|SATURDAY, March 13, 2010
|6:45 ‑ 7:30 ||Registration and Continental Breakfast|
|7:30 ‑ 7:45 ||Welcome and Course Introduction|
Marc B. Garnick, MD
|7:45 ‑ 8:25 ||Risk Reduction for Malpractice Claims Related to Cancer: The RMF Perspective|
Ann Louise Puopolo, BSN, RN
|8:25 ‑ 9:05 ||Reducing Risk for Medical Malpractice: A Defense Attorney’s Perspective|
Ellen Epstein Cohen, JD
|9:05 ‑ 9:40 ||Considerations for the Primary Care Physician Related to Colorectal Cancer Screening|
Helen Shields, MD
|9:40 ‑ 10:30 ||Case Studies of Medical Malpractice in Colorectal Cancer and Decision Support Tools|
Moderator: Helen Shields, MD
Panelists: Ellen Epstein Cohen, JD; Ann Louise Puopolo, BSN, RN
|10:30 ‑ 10:45 ||Break|
|10:45 ‑ 11:15 ||Considerations for the Primary Care Physician Related to Breast Cancer Screening and Mammographic Follow‑up|
Susan Troyan, MD
|11:15 ‑ 11:45 ||Genetic Counseling|
Nadine Tung, MD
|11:45 ‑ 12:30 ||Case Studies of Medical Malpractice in Breast Cancer and Decision Support Tools|
Moderator: Lowell E. Schnipper, MD
Panelists: Ellen Epstein Cohen, JD; Jennifer Potter, MD; Ann Louise Puopolo, BSN, RN; Susan Troyan, MD; Nadine Tung, MD
|12:30 ‑ 1:30 ||LUNCH AND PRESENTATION: Experiencing a Medical Malpractice Claim: A Physician’s Perspective|
Beth Cushing, JD; Mark Horgan, JD
|1:30 ‑ 2:00 ||Considerations for the Primary Care Physician Related to Prostate Cancer Screening|
Michael J. Barry, MD
|2:00 ‑ 2:45 ||Case Studies of Medical Malpractice in Prostate Cancer and Decision Support Tools|
Moderator: Marc B. Garnick, MD
Panelists: Michael J. Barry, MD; Kevin Loughlin, MD, MBA
|2:45 ‑ 3:00 ||Break|
|3:00 ‑ 3:30 ||Considerations for the Primary Care Physician Related to Lung Cancer Screening, Evaluation and Reporting of Pulmonary Radiographs|
Paul Spirn, MD
|3:30 ‑ 4:15 ||Case Studies of Medical Malpractice in Lung Cancer and Decision Support Tools|
Moderator: Mark Horgan, JD
Panelists: Mark Huberman, MD; Paul Spirn, MD
|4:15 ||Closing Remarks and Evaluation|
Marc B. Garnick, MD
Back to top >>
Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing
medical education for physicians. Harvard Medical School designates this educational activity for a maximum of 8 AMA PRA
Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A portion of this program has been designed to meet the criteria for 3.5 hours of risk management credit in Massachusetts.
Back to top >>
Physician and Allied Health Professional $250
Paralegal; Medical/Law Student $99
Insurance Company Professional/Claims Representative $350
All foreign payments must be made by a draft on a United States Bank or by Visa or MasterCard.
If paying by CHECK, please make payable to Harvard Medical School and mail with completed registration form to Harvard Medical School - Department of Continuing Education, PO Box 825, Boston, MA 02117-0825.
If paying by credit card, please register online via the REGISTER NOW! link above.
Telephone or mail-in registration with credit card payment is not accepted.
Inquiries should be directed to the above address, made by phone: (617) 384-8600, Monday - Friday, 10 AM to 4 PM (EST), or by email: email@example.com
Upon receipt of your registration form an email confirmation from the HMS-DCE office will be sent to you. Therefore, be sure to include an email address that you check daily/frequently. Your email address is used for critical information about the course including; registration confirmation, course evaluation and certificate.
Back to top >>
TUITION REFUND POLICY
A handling fee of $60 is deducted for cancellation. Refund requests must be received by mail one week prior to the course. No refunds will be made thereafter.
The course will be held at the Fairmont Copley Plaza Hotel, 138 St. James Avenue, Boston, MA 02116.
A limited number of rooms have been
reserved at the Fairmont Copley Plaza Hotel. To make a reservation and receive a reduced room rate, call 617‑267‑5300 or 1‑800‑795‑3906
(https://resweb.passkey.com/go/medicalmalpractice) no later than February 19, 2010, and specify that you are enrolled in this course. Hotel
rooms in Boston are limited. You are urged to make your reservation early. A map of Boston listing other local hotels will be sent with your enrollment
confirmation. For additional housing assistance, call Boston Reservations at 617‑332‑4199.
Back to top >>
Please do not make non-refundable airline reservations until you have received course confirmation. You can make your airline reservation by calling: the HMS Travel Desk toll free 1-877-4HARVMD (1-877-442-7863) Monday—Friday 9 am—8 pm (EST). From outside the U.S., Canada and Virgin Islands, please call 617-559-3764.
Back to top >>
|HARVARD MEDICAL SCHOOL COURSE DIRECTORS
|MARC B. GARNICK, MD|
Clinical Professor of Medicine Harvard Medical School, Boston MA, Medical Oncologist, Beth Israel Deaconess Medical Center, Boston, MA
|LOWELL E. SCHNIPPER, MD|
Theodore and Evelyn Berenson Professor of Medicine, Harvard Medical School, Boston, MA, Chief, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA
|ELLEN EPSTEIN COHEN, JD|
Attorney, Adler, Cohen, Harvey, Wakeman & Guekguezian, LLP, Boston, MA Elizabeth A. Cushing, JD Claims Manager , CRICO - Risk Management Foundation Cambridge, MA
|RISK MANAGEMENT FOUNDATION OF
HARVARD MEDICAL INSTITUTIONS FACULTY
|ANN LOUISE PUOPOLO, BSN, RN|
Director, Loss Prevention and Patient Safety, CRICO - Risk Management Foundation, Cambridge, MA
|ELIZABETH CUSHING, JD|
Director of Claims
|MARK HORGAN, JD|
Vice President, Claims, Loss Prevention and Patient Safety, CRICO - Risk Management Foundation, Cambridge, MA
|HARVARD MEDICAL SCHOOL COURSE FACULTY
|MICHAEL J. BARRY, MD|
Professor of Medicine, Harvard Medical School, Boston, MA, Chief, General Medicine Unit, Massachusetts General Hospital Boston, MA
|MARK HUBERMAN, MD|
Assistant Professor of Medicine ,Harvard Medical School, Boston, MA, Director, Thoracic Oncology Program, Beth Israel Deaconess Medical Center, Boston, MA
|KEVIN LOUGHLIN, MD, MBA|
Professor of Surgery/Urology, Harvard Medical School, Boston, MA, Director of Urologic Research, Division of Urology, Brigham and Women's Hospital, Boston, MA,
|DEBORAH NAGLE, MD|
Instructor in Surgery, Harvard Medical School, Boston, MA, Chief, Colon and Rectal Surgery, Beth Israel Medical Deaconess Medical Center, Boston, MA
|JENNIFER POTTER, MD|
Associate Professor of Medicine Harvard Medical School, Boston, MA, Physician, Women's Health, Beth Israel Deaconess Medical Center, Boston, MA,
|HELEN SHIELDS, MD|
Associate Professor of Medicine Harvard Medical School, Boston, MA, Physician, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA , Chairman, Colorectal Cancer Advisory Group, CRICO/Risk Management Foundation, Cambridge, MA
|PAUL SPIRN, MD|
Assistant Professor of Radiology, Harvard Medical School, Boston, MA, Diagnostic Radiologist, Department of Radiology, Beth Israel Deaconess Hospital Boston, MA
|SUSAN TROYAN, MD|
Instructor, Surgery, Harvard Medical School, Boston, MA, Director, Breast Care Program, Beth Israel Deaconess Medical Center, Boston, MA
|NADINE TUNG, MD|
Assistant Professor of Medicine, Harvard Medical School, Boston, MA, Medical Oncologist, Beth Israel Deaconess Medical Center, Boston, MA
Back to top >>
Last Updated 12.20.2009
Earn up to
8 CME Credits
3.5 Hrs Risk Management (MA)
Department of Medicine and
Division of Oncology
Marc B. Garnick, M.D. is an internationally renowned expert on urologic cancer. He maintains an active practice, specializing in prostate cancer and outcomes for early detection of cancers at Beth Israel Deaconess Medical Center (BIDMC); is Clinical Professor of Medicine, Harvard Medical School and BIDMC; Medical Director, Oncology Services, Northeast Hospital Corporation; Editor in Chief, Perspectives on Prostate Disease, (Harvard Health Publications); his research includes biotechnology and drug development and is founder of the Hershey Family Foundation for Basic and Clinical Prostate Cancer Research, at BIDMC.
Dr. Garnick has authored more than 350 written works, including 5 books, peer reviewed articles and letters and serves on several editorial boards for peer-reviewed publications. Publications include an article that he co-authored entitled "Combating Prostate Cancer" which appeared in Scientific American; a book entitled A Patient's Guide to Prostate Cancer and Screening for Prostate Cancer published by the American College of Physicians, Physician Information and Education Resource. He is also the senior medical advisor to World Book Encyclopedia. Dr. Garnick serves as a consultant for Best Doctors and received the Distinguished Alumni Service Award from the University of Pennsylvania School of Medicine.
Lowell E. Schnipper, M.D. is Chief of the Division of Hematology/Oncology at Beth Israel Deaconess Medical Center and Theodore W. and Evelyn G. Berenson Professor at Harvard Medical School. He is also an Associate Director of the Dana-Farber/Harvard Cancer Center for membership, Deputy Associate Director for Clinical Sciences and a member of its executive committee.
Dr. Schnipper is deeply committed to oncology research, having receiving numerous grants from the National Cancer Institute and American Cancer Society, and publishing more than 120 papers on subjects ranging from developing new anti-viral and anti-cancer therapies to the basic biology of cancer.
Dr. Schnipper has built a program boasting 40 physicians and scientists whose goals are to achieve clinical excellence through scientific understanding of cancer coupled with personalized care. Among the unique initiatives that have come about under his leadership is a molecular imaging program aimed at identifying cancer at its most minimal stage, a research program on the origins of leukemia, and translational research in tumor vaccines and prostate cancer. He is a recipient of a Distinguished Public Service Award from the American Society of Clinical Oncology.